Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohns disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study
Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohns disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study